Published on: January 30, 2018 at 12:00PM
Condition: Breast Cancer
Interventions: Drug: Vinorelbine; Drug: Trastuzumab; Drug: Avelumab; Drug: Utomilumab
Sponsors: Ian E. Krop, MD, PhD; Pfizer; Breast Cancer Research Foundation; Johns Hopkins University
Not yet recruiting
http://ift.tt/2BFObGd
No comments:
Post a Comment